Catherine C. Coombs, MD, presents a patient case and provides clinical insights on evolving treatment paradigms for patients with relapsed/refractory CLL.
EP. 1: Patient Profile: A 70-Year-Old Man with Relapsed/Refractory CLL
Catherine C. Coombs, MD, presents the case of a 70-year-old man with relapsed/refractory chronic lymphocytic leukemia and offers her initial impressions.
Watch
EP. 2: CLL: Prognostic Factors and Treatment Considerations
An expert on chronic lymphocytic leukemia discusses disease progression and prognostic factors that influence treatment decisions.
EP. 3: Overview of Treatment Options for Relapsed/Refractory CLL
Catherine C. Coombs, MD, reviews currently available treatment options for patients with relapsed/refractory chronic lymphocytic leukemia.
EP. 4: MURANO: Venetoclax Plus Rituximab in Patients With Relapsed/Refractory CLL
An expert oncologist reviews the MURANO trial of venetoclax plus rituximab in patients with relapsed/refractory CLL and discusses MRD as a parameter of treatment response.
EP. 5: Recent Data on CAR T-Cell Therapy and BTK Inhibitors in Relapsed/Refractory CLL
An overview of recent data from ongoing trials evaluating CAR T-cell therapy and BTK inhibitors in patients with relapsed/refractory CLL.
EP. 6: Unmet Needs and Clinical Pearls for Treating Relapsed/Refractory CLL
Catherine C. Coombs, MD, discusses unmet needs and offers advice for community oncologists treating patients with relapsed/refractory chronic lymphocytic leukemia.